Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +44.37%
#2 Bitway Bitway +38.72%
#3 Pons Pons +35.79%
#4 Starpower Starpower +33.84%
#5 Mubarak Mubarak +32.84%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#7 Ocean Protocol Ocean Protocol +27.09%
#8 SkyAI SkyAI +25.60%
#9 StonkBroker StonkBroker +19.21%
#10 PondCoin PondCoin +18.51%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rank in Stocks #29206
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Share Price
$2.77
Market Cap
$22.40M
Change (1 day)
-0.93%
Change (1 year)
-17.48%
Country
JP
Trade Kringle Pharma, Inc. (4884)

Category

Healthcare
Number of shares outstanding for Kringle Pharma, Inc. (4884)
Number of shares outstanding as of August 2026: 0
According to Kringle Pharma, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Kringle Pharma, Inc. (4884) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH